Reduced Frequency of Prolonged Sporadic Hemiplegic Migraine Attacks Following Fremanezumab Treatment—A Case Report
This case illustrates the diagnostic complexity of SHM and adds to the growing body of anecdotal observations suggesting that CGRP monoclonal antibodies may be a promising preventive treatment for patients with HM. Further studies are needed to evaluate their efficacy in this rare migraine subtype.
Authors
- Stefan Krebs
- Robert Han
- Marion Vigl
- Julia Ferrari
- Paolo Gallmetzer
- Marek Sykora
- Lisa Kaindl
- Lavinia Ritscher
- Christian Neumann
- Julian Frederic Hotz
Institutions
- Sigmund Freud Privatuniversität Wien (AT)
- St. John's Hospital (US)
- Hospital of the Brothers of St. John of God (AT)
- Medical University of Vienna (AT)
Publication Details
- Journal
- European Journal of Neurology
- Published
- 2026-01-27
- DOI
- https://doi.org/10.1111/ene.70514
- Primary Topic
- Migraine and Headache Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00